list of glp-1 drugs approved and pending medications The Boom in New Weight
Description
People taking GLP-1 receptor agonists may become dehydrated from vomiting or diarrhea, causing kidney problems

In the SURPASS-2 study, tirzepatide 15 mg resulted in a faster and greater decline in body weight ( 5.5 kg) compared to semaglutide 1.0 mg, more than doubling the proportion of patients achieving at least 10% weight loss (57% vs 24%) [3]
GLP-1RAs (e.g., exenatide and liraglutide) appear effective in modulating BAT thermogenesis and browning, controlling food intake, and increasing energy expenditure through the action on the hypothalamic AMPK pathway, with clinically significant effects

In HF, the heart loses its metabolic adaptability, which throws energy metabolism into disarray
